» Articles » PMID: 29891548

Gain-of-Function Analysis Reveals Important Virulence Roles for the Yersinia Pestis Type III Secretion System Effectors YopJ, YopT, and YpkA

Overview
Journal Infect Immun
Date 2018 Jun 13
PMID 29891548
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Virulence of in mammals requires the type III secretion system, which delivers seven effector proteins into the cytoplasm of host cells to undermine immune responses. All seven of these effectors are conserved across strains, but three, YopJ, YopT, and YpkA, are apparently dispensable for virulence. Some degree of functional redundancy between effector proteins would explain both observations. Here, we use a combinatorial genetic approach to define the minimal subset of effectors required for full virulence in mice following subcutaneous infection. We found that a strain lacking YopJ, YopT, and YpkA is attenuated for virulence in mice and that addition of any one of these effectors to this strain increases lethality significantly. YopJ, YopT, and YpkA likely contribute to virulence via distinct mechanisms. YopJ is uniquely able to cause macrophage cell death and to suppress accumulation of inflammatory cells to foci of bacterial growth in deep tissue, whereas YopT and YpkA cannot. The synthetic phenotypes that emerge when YopJ, YopT, and YpkA are removed in combination provide evidence that each effector enhances virulence and that YopT and YpkA act through a mechanism distinct from that of YopJ.

Citing Articles

actively inhibits the production of extracellular vesicles by human neutrophils.

Sheneman K, Cummins T, Merchant M, Hood J, Uriarte S, Lawrenz M bioRxiv. 2025; .

PMID: 39763979 PMC: 11702605. DOI: 10.1101/2024.12.20.629761.


Approaches for the Inactivation of .

Brady A, Tomaszewski M, Garrison T, Lawrenz M Appl Biosaf. 2024; 29(4):221-231.

PMID: 39735406 PMC: 11669761. DOI: 10.1089/apb.2023.0022.


Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB Synthesis in Neutrophils versus Macrophages.

Brady A, Mora-Martinez L, Hammond B, Haribabu B, Uriarte S, Lawrenz M bioRxiv. 2024; .

PMID: 39005373 PMC: 11244889. DOI: 10.1101/2024.07.01.601466.


Pathogenicity and virulence of .

Seabaugh J, Anderson D Virulence. 2024; 15(1):2316439.

PMID: 38389313 PMC: 10896167. DOI: 10.1080/21505594.2024.2316439.


Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition.

Brady A, Sheneman K, Pulsifer A, Price S, Garrison T, Maddipati K PLoS Pathog. 2024; 20(1):e1011280.

PMID: 38271464 PMC: 10846697. DOI: 10.1371/journal.ppat.1011280.


References
1.
Degen J, Bugge T, Goguen J . Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost. 2007; 5 Suppl 1:24-31. DOI: 10.1111/j.1538-7836.2007.02519.x. View

2.
Pechous R, Sivaraman V, Price P, Stasulli N, Goldman W . Early host cell targets of Yersinia pestis during primary pneumonic plague. PLoS Pathog. 2013; 9(10):e1003679. PMC: 3789773. DOI: 10.1371/journal.ppat.1003679. View

3.
Spinner J, Cundiff J, Kobayashi S . Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function. Infect Immun. 2008; 76(8):3754-60. PMC: 2493194. DOI: 10.1128/IAI.00385-08. View

4.
Pouliot K, Pan N, Wang S, Lu S, Lien E, Goguen J . Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis. Infect Immun. 2007; 75(7):3571-80. PMC: 1932965. DOI: 10.1128/IAI.01644-06. View

5.
Akopyan K, Edgren T, Wang-Edgren H, Rosqvist R, Fahlgren A, Wolf-Watz H . Translocation of surface-localized effectors in type III secretion. Proc Natl Acad Sci U S A. 2011; 108(4):1639-44. PMC: 3029700. DOI: 10.1073/pnas.1013888108. View